Gerard Michel
Chief Executive Officer bei DELCATH SYSTEMS, INC.
Vermögen: 2 Mio $ am 30.04.2024
Profil
Gerard J.
Michel is currently the President, Chief Executive Officer & Director at Delcath Systems, Inc. He previously held positions as Director at EP MedSystems, Inc. from 2007 to 2008, Chief Financial Officer & VP-Corporate Development at NPS Pharmaceuticals, Inc. from 2002 to 2007, Chief Financial Officer & VP-Corporate Development at Vericel Corp.
from 2014 to 2020, CFO, Treasurer & VP-Corporate Development at Biodel, Inc. from 2007 to 2014, and Principal at Booz Allen Hamilton International (U.K.) Ltd.
from 1995 to 2002.
Mr. Michel obtained an undergraduate degree from Rochester Christian University, a graduate degree from the University of Rochester Medical Center, and an MBA from the University of Rochester Simon Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DELCATH SYSTEMS, INC.
1,37% | 28.03.2024 | 302 668 ( 1,37% ) | 2 Mio $ | 30.04.2024 |
Aktive Positionen von Gerard Michel
| Unternehmen | Position | Beginn |
|---|---|---|
| DELCATH SYSTEMS, INC. | Chief Executive Officer | 01.10.2020 |
Ehemalige bekannte Positionen von Gerard Michel
| Unternehmen | Position | Ende |
|---|---|---|
| VERICEL CORPORATION | Director of Finance/CFO | 30.09.2020 |
Biodel, Inc.
 Biodel, Inc. Pharmaceuticals: MajorHealth Technology Biodel, Inc. is a pharmaceutical company, which develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. The company develops product candidates by applying formulation technologies to existing drugs in order to improve their therapeutic profiles. Biodel was founded by Solomon S. Steiner and Erik Steiner on December 3, 2003 and is headquartered in Danbury, CT. | Director of Finance/CFO | 01.05.2014 |
EP MedSystems, Inc.
 EP MedSystems, Inc. Medical SpecialtiesHealth Technology EP MedSystems, Inc. manufactures medical equipment for visualization, diagnosis, and treatment of cardiac rhythm disorders. Its EP-3 Stimulator is a computerized electrophysiology clinical stimulator; EP-WorkMate monitor heart activity and stores arrhythmia data; and EP's ALERT system, treats arrhythmia by delivering low levels of electricity to the heart through a catheter. The company was founded in 1993 and is headquartered in West Berlin, NJ. | Director/Board Member | 07.07.2008 |
| NPS PHARMACEUTICALS, INC. | Director of Finance/CFO | 01.11.2007 |
Booz Allen Hamilton International (U.K.) Ltd.
 Booz Allen Hamilton International (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Booz Allen & Hamilton International provides management and technology consulting services. The company provides services to international corporations and governments around the world. It was founded in 1914 and is located in McLean, VA. | Corporate Officer/Principal | 01.07.2002 |
Ausbildung von Gerard Michel
| Rochester Christian University | Undergraduate Degree |
| University of Rochester Medical Center | Graduate Degree |
| University of Rochester Simon Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| VERICEL CORPORATION | Health Technology |
| DELCATH SYSTEMS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
EP MedSystems, Inc.
EP MedSystems, Inc. Medical SpecialtiesHealth Technology EP MedSystems, Inc. manufactures medical equipment for visualization, diagnosis, and treatment of cardiac rhythm disorders. Its EP-3 Stimulator is a computerized electrophysiology clinical stimulator; EP-WorkMate monitor heart activity and stores arrhythmia data; and EP's ALERT system, treats arrhythmia by delivering low levels of electricity to the heart through a catheter. The company was founded in 1993 and is headquartered in West Berlin, NJ. | Health Technology |
Biodel, Inc.
Biodel, Inc. Pharmaceuticals: MajorHealth Technology Biodel, Inc. is a pharmaceutical company, which develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. The company develops product candidates by applying formulation technologies to existing drugs in order to improve their therapeutic profiles. Biodel was founded by Solomon S. Steiner and Erik Steiner on December 3, 2003 and is headquartered in Danbury, CT. | Health Technology |
Booz Allen Hamilton International (U.K.) Ltd.
Booz Allen Hamilton International (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Booz Allen & Hamilton International provides management and technology consulting services. The company provides services to international corporations and governments around the world. It was founded in 1914 and is located in McLean, VA. | Commercial Services |
